Furthermore , Kampala participants ( the largest site ) receiving early ART had higher day-14 CSF levels of interleukin-13 ( P = .04 ) , sCD14 ( P = .04 ) , sCD163 ( P = .02 ) , and CCL3/MIP -1 ( P = .02 ) , suggesting increased macrophage/microglial activation .